Cabaletta Bio, Inc. - Common Stock (NQ:CABA)

2.080 +0.080 (+4.00%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cabaletta Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

This C3.ai Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday ↗

December 19, 2024

Via Benzinga

Peering Into Cabaletta Bio's Recent Short Interest ↗

December 16, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 02, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 29, 2024

Via Benzinga

US Stocks Likely To Open In The Green To End November On A High: Are Markets Set For A Santa Claus Rally In December? Analysts Decode ↗

November 29, 2024

U.S. stock futures advanced on Friday after a day's break for Thanksgiving as investors look to end November on a high note.

Via Benzinga

Recap: Cabaletta Bio Q4 Earnings ↗

March 21, 2024

Via Benzinga

Caballeta Bio Shares Surge The Most In 23 Months In A Single Day As It Unveils Plan To Meet FDA By 2025 For Systemic Sclerosis Drug Trial ↗

November 28, 2024

Via Benzinga

Cabaletta Bio to Participate in Upcoming Investor Conferences in December

November 26, 2024

From Cabaletta Bio

Via GlobeNewswire

Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024

November 18, 2024

From Cabaletta Bio

Via GlobeNewswire

Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update

November 14, 2024

From Cabaletta Bio

Via GlobeNewswire

Cabaletta Bio to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference

November 06, 2024

From Cabaletta Bio

Via GlobeNewswire

Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR Convergence 2024

September 25, 2024

From Cabaletta Bio

Via GlobeNewswire

Cabaletta Bio to Participate in Upcoming Investor Conferences in September

August 28, 2024

From Cabaletta Bio

Via GlobeNewswire

CABA Stock Earnings: Cabaletta Bio Misses EPS for Q2 2024 ↗

August 08, 2024

CABA stock results show that Cabaletta Bio missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update

August 08, 2024

From Cabaletta Bio

Via GlobeNewswire

Cell Therapy Mostly Used For Blood Cancer Shows Efficacy In Autoimmune Diseases As Well, But There Are Challenges ↗

July 19, 2024

CAR-T therapy, originally used for blood cancers, shows promising results in treating lupus, as evidenced by Janina Paech's remarkable remission. This breakthrough offers new hope for autoimmune...

Via Benzinga

Cabaletta Bio to Participate in the Stifel 2024 Virtual Cell Therapy Forum

July 02, 2024

From Cabaletta Bio

Via GlobeNewswire

Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 21, 2024

Via Benzinga

Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday ↗

June 21, 2024

Via Benzinga

Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 18, 2024

Via Benzinga

Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 14, 2024

Via Benzinga

Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201

June 14, 2024

From Cabaletta Bio

Via GlobeNewswire

Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference

May 29, 2024

From Cabaletta Bio

Via GlobeNewswire

Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 15, 2024

Via Benzinga

CABA Stock Earnings: Cabaletta Bio Misses EPS for Q1 2024 ↗

May 15, 2024

CABA stock results show that Cabaletta Bio missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

NEXTracker Posts Upbeat Earnings, Joins monday.com, Nu Holdings And Other Big Stocks Moving Higher On Wednesday ↗

May 15, 2024

Via Benzinga

Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update

May 15, 2024

From Cabaletta Bio

Via GlobeNewswire

Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

May 13, 2024

From Cabaletta Bio

Via GlobeNewswire

CABA Stock Earnings: Cabaletta Bio Misses EPS for Q4 2023 ↗

March 21, 2024

CABA stock results show that Cabaletta Bio missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

March 21, 2024

From Cabaletta Bio

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.